docetaxel anhydrous has been researched along with Adenocarcinoma, Papillary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ángeles-Bueno, WG; Díaz-Sifuentes, JM; Mendoza-Medina, DF; Mendoza-Sánchez, F; Montes-López, GA; Pérez-Landeros, JE | 1 |
Alahwal, MS; Rouzi, AA; Sahly, NF; Sahly, NN | 1 |
Aoki, D; Eguchi, F; Fujiwara, K; Jobo, T; Katsumata, N; Kitagawa, R; Kohno, I; Kuramoto, H; Nishimura, R; Noda, K; Nozawa, S; Sohda, Y; Susumu, N; Ueki, K; Ueki, M; Yamaguchi, S | 1 |
1 review(s) available for docetaxel anhydrous and Adenocarcinoma, Papillary
Article | Year |
---|---|
Use of synthetic stomata in abdominal carcinomatosis. Case report and literature review.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; Argon Plasma Coagulation; Bevacizumab; Carboplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Doxorubicin; Drainage; Fatal Outcome; Female; Humans; Hyperthermia, Induced; Intestinal Neoplasms; Intestinal Perforation; Mitomycin; Ovarian Neoplasms; Polyethylene Glycols; Surgical Stomas | 2019 |
1 trial(s) available for docetaxel anhydrous and Adenocarcinoma, Papillary
Article | Year |
---|---|
Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cystadenocarcinoma, Serous; Docetaxel; Endometrial Neoplasms; Female; Humans; Japan; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate; Taxoids | 2005 |
1 other study(ies) available for docetaxel anhydrous and Adenocarcinoma, Papillary
Article | Year |
---|---|
Cisplatinum and docetaxel for ovarian cancer in pregnancy.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Cesarean Section; Cisplatin; Docetaxel; Fatal Outcome; Female; Humans; Infant, Newborn; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Taxoids | 2009 |